arrow
Back
R

Rodryg Ramlau

Poznan University of Medical Sciences

53H-index
381Paper Count
2.3WCitation Count
Published Papers 49
Publication Date
Breast Cancer Multicellular Spheroid Models—A Tool for Studying Cancer Biology; a Possible Platform for Drug Screening and Personalized Medicine
err2026-01-28
err0
errOAAI
errMaksymilian Kolodziej; Jakub Czarny; Hanna Dyla; Dominika Rekawek; Maria Zlotek; Alicja Wlodarz; Michal Baranowicz; Eliza Kwiatkowska-Borowczyk; Olga Milbrandt; Rodryg Ramlau; Hanna Dams-Kozlowska
errShare
errSave
Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study
err2025-05-08
err0
errOAAI
errGlenwood Goss; Tudor Ciuleanu; Rodryg Ramlau; Daniel J. Renouf; Quincy Chu; Ewa Kalinka; Piotr Sawrycki; Jonathan Bramson; Brad H. Nelson; Rafael Crabbé; Eric LaCasse; Bryan Lo; Daniela A. Sahlender; Philippa Crompton; Franck Brichory; Luke Piggott; Michael Schenker; Rosalyn Juergens
errShare
errSave
Leveraging innate and adaptive immunity with AFM24 and atezolizumab in metastatic gastric cancer
err2024-09-01
err0
PREAI
errSanta Gadea, O. Saavedra; Oberoi, A.; Lopez, J. S.; Cervantes, A.; Ponz-Sarvise, M.; Kim, H. R.; El-Khoueiry, A. B.; Shim, B.; Kim, J. W.; Boni, V.; Lugowska, I.; Szczylik, C.; Rogowski, W.; Mandziuk, S.; Ramlau, R.; Gaertner, U.; Lutkewitz, S.; Schuetz, D.; Emig, M.; Morales-Espinosa, D.
errShare
errSave
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations
err2024-04-16
err1
errOAAI
errNecchi, Andrea; Ramlau, Rodryg; Falcon Gonzalez, Alejandro; Chaudhry, Arvind; Todenhoefer, Tilman; Tahbaz, Rana; Fontana, Elisa; Giannatempo, Patrizia; Deville, Jean-Laurent; Pouessel, Damien; Yoon, Shinkyo; Powles, Thomas; Bernat, Mathieu; Hackl, Manuel; Marszewska, Michalina; McKernan, Phil; Saulay, Mikael; Scaleia, Federica; Engelhardt, Marc; Loriot, Yohann; Siefker-Radtke, Arlene; De Santis, Maria
errShare
errSave
Xevinapant plus avelumab in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC): Phase 1b dose-expansion results and exploratory biomarker analyses
err2023-04-14
err0
PREAI
errChu, Quincy; Ciuleanu, Tudor; Ramlau, Rodryg; Renouf, Daniel; Juergens, Rosalyn; Kalinka, Ewa; Sawrycki, Piotr; Bramson, Jonathan; Nelson, Brad; Crabbe, Rafael; Sahlender, Daniela A.; Crompton, Philippa; Rouits, Elisabeth; Spaggiari, Dany; Brichory, Franck; Piggott, Luke; Schenker, Mike; Goss, Glenwood
errShare
errSave
A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives
errCELLS
IF5.2
err2023-03-15
err6
errOAAI
errSulewska, Anetta; Pilz, Lothar; Manegold, Christian; Ramlau, Rodryg; Charkiewicz, Radoslaw; Niklinski, Jacek
errShare
errSave
Fertility Counseling in BRCA1/2-Mutated Women with Breast Cancer and Healthy Individuals
err2022-07-10
err10
errOAAI
errKufel-Grabowska, Joanna; Podolak, Amira; Maliszewski, Daniel; Bartoszkiewicz, Mikolaj; Ramlau, Rodryg; Lukaszuk, Krzysztof
errShare
errSave
The significance of interferon gamma inducible protein 16 (IFI16) expression in drug resistant ovarian cancer cell lines
err2022-06-01
err7
errOAAI
errBorucka, Justyna; Sterzynska, Karolina; Kazmierczak, Dominika; Swierczewska, Monika; Nowacka, Marta; Wojtowicz, Karolina; Klejewski, Andrzej; Nowicki, Michal; Zabel, Maciej; Ramlau, Rodryg; Januchowski, Radoslaw
errShare
errSave
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA
err2022-05-01
err5
errOAAI
errRemon, Jordi; Lacas, Benjamin; Herbst, Roy; Reck, Martin; Garon, Edward B.; Scagliotti, Giorgio V.; Ramlau, Rodryg; Hanna, Nasser; Vansteenkiste, Johan; Yoh, Kiyotaka; Groen, Harry J. M.; Heymach, John V.; Mandrekar, Sumithra J.; Okamoto, Isamu; Neal, Joel W.; Heist, Rebecca S.; Planchard, David; Pignon, Jean-Pierre; Besse, Benjamin
errShare
errSave
The predictive value of circulating tumor DNA dynamics in plasma of EGFR-mutation-positive NSCLC patients on first line tyrosine kinase inhibitors
err2021-11-25
err0
PREAI
errSzpechcinski, Adam; Bryl, Maciej; Czyzewicz, Grzegorz; Wojda, Emil; Swiniuch, Daria; Szwiec, Marek; Ramlau, Rodryg; Sliwinski, Pawel; Barinow-Wojewodzki, Aleksander; Chorostowska-Wynimko, Joanna
errShare
errSave
A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression
err2021-09-01
err2
errOAAI
errAndric, Z.; Ceric, T.; Rancic, M.; Jakopovic, M.; Aix, S. Ponce; Ramlau, R.; Ulanska, M.; Caldwell, C.; Ferrari, D.; Annis, A.; Vukovic, V.; Zaric, B.
errShare
errSave
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial
err2021-04-01
err12
errOAAI
errCamerini, A.; Morabito, A.; Montanino, A.; Bernabe, R.; Grossi, F.; Ramlau, R.; Ciuleanu, T-E; Ceresoli, G-L; Pasello, G.; de Marinis, F.; Bosch-Barrera, J.; Laundreau, P.; Gautier, S.; Minh, C. Ta Thanh; Kowalski, D.
errShare
errSave
Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
err2021-03-24
err14
errOAAI
errBozyk, Aleksandra; Krawczyk, Pawel; Reszka, Katarzyna; Krukowska, Kinga; Kolak, Agnieszka; Mandziuk, Slawomir; Wojas-Krawczyk, Kamila; Ramlau, Rodryg; Milanowski, Janusz
errShare
errSave
Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients
err2021-02-08
err13
errOAAI
errGrenda, Anna; Krawczyk, Pawel; Blach, Justyna; Chmielewska, Izabela; Kubiatowski, Tomasz; Kieszko, Stanislaw; Wojas-Krawczyk, Kamila; Kucharczyk, Tomasz; Jarosz, Bozena; Pasnik, Iwona; Borowiec-Bar, Malgorzata; Frak, Malgorzata; Kieszko, Robert; Szczyrek, Michal; Reszka, Katarzyna; Krukowska, Kinga; Kolak, Agnieszka; Mandziuk, Slawomir; Kowalski, Dariusz; Sawicki, Marek; Swiniuch, Daria; Staroslawska, Elzbieta; Ramlau, Rodryg; Szumilo, Justyna; Krzakowski, Maciej; Milanowski, Janusz
errShare
errSave
Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
err2020-01-01
err2
errOAAI
errNicos, Marcin; Wojas-Krawczyk, Kamila; Krawczyk, Pawel; Chmielewska, Izabela; Wojcik-Superczynska, Magdalena; Reszka, Katarzyna; Kieszko, Robert; Gora-Florek, Anna; Dudek, Malgorzata; Swiniuch, Daria; Papiewski, Wojciech; Calka, Paulina; Ciesielka, Marzanna; Ramlau, Rodryg; Milanowski, Janusz
errShare
errSave
Dynamic monitoring of EGFR mutations in circulating tumor DNA for early detection of drug resistance in NSCLC patients on EGFR-TKI therapy
err2019-11-21
err0
PREAI
errSzpechcinski, Adam; Bryl, Maciej; Czyzewicz, Grzegorz; Wojda, Emil; Swiniuch, Daria; Szwiec, Marek; Rudzinski, Stefan; Duk, Katarzyna; Ramlau, Rodryg; Sliwinski, Pawel; Barinow-Wojewodzki, Aleksander; Chorostowska-Wynimko, Joanna
errShare
errSave
Final results of Phase II STELLAR trial: TTFields with chemotherapy in unresectable malignant pleural mesothelioma
err2019-07-01
err4
PREAI
errCeresoli, Giovanni Luca; Aerts, Joachim; Madrzak, Jaroslaw; Dziadziuszko, Rafal; Ramlau, Rodryg; Cedres, Susana; Hiddinga, Birgitta; VanMeerbeeck, Jan; Mencoboni, Manlio; Planchard, David; Chella, Antonio; Crino, Lucio; Krzakowski, Maciej; Grosso, Federica
errShare
errSave
Tumor Treating Fields plus chemotherapy for first-line treatment of malignant pleural mesothelioma: Final Results of the STELLAR Trial
err2019-05-01
err1
PREAI
errCeresoli, G.; Aerts, J.; Madrzak, J.; Dziadziuszko, R.; Ramlau, R.; Cedres, S.; Hiddinga, B.; Van Meerbeeck, J. P.; Mencoboni, M.; Planchard, D.; Chella, A.; Krzakowski, M.; Crino, L.; Grosso, F.
errShare
errSave